A multi-analyte assay for the non-invasive detection of bladder cancer.
Accurate urinary assays for bladder cancer (BCa) detection would benefit both patients and healthcare systems. Through genomic and proteomic profiling of urine components, we have previously identified a panel of biomarkers that can outperform current urine-based biomarkers for the non-invasive dete...
Main Authors: | Steve Goodison, Myron Chang, Yunfeng Dai, Virginia Urquidi, Charles J Rosser |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23094052/?tool=EBI |
Similar Items
-
CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
by: Virginia Urquidi, et al.
Published: (2012-01-01) -
IL-8 as a urinary biomarker for the detection of bladder cancer
by: Urquidi Virginia, et al.
Published: (2012-05-01) -
Multiplex Urinary Tests for Bladder Cancer Diagnosis
by: Virginia Urquidi, et al.
Published: (2013-12-01) -
Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection
by: Hideki Furuya, et al.
Published: (2020-11-01) -
Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
by: Yosuke Hirasawa, et al.
Published: (2021-04-01)